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Diabetic Nephropathy S7Methods: Bring into the DKD patients through pathological diagnosis which
have more than one year disease course, to classify by the Tervaet criterion
of pathological stage of DKD, to differentiate the syndrome differentiation
in TCM by collecting clinical data, and have a statistical processing at last.
Results: We collected 353 DKD patients meeting the criterion in total, clas-
sified by the pathological stage criterion of DKD, among them there were 52
patients with phase I, 90 patients with phase IIa, 29 patients with phase
IIb,141 patients with phase III, 41 patients with phase IV. About syndrome
differentiation, there were 13 patients with Yin-Xu-Zao-Re type, there
were 151 patients with Qi-Yin-Liang-Xu type, there were 140 patients with
Pi-Shen-Qi-Xu type, there were 49 patients with Yin-Yang-Liang-Xu type,
there were 19 patients with Han-Shi type, there were 68 patients with Shi-
Re type, there were 212 patients with Yu-Xue type, there were 54 patients
with Tan-Yu type. In the patients with Yin-Xu-Zao-Re type, the renal inter-
stitial inflammation was more serious than other typs. In the patients with
Pi-Shen-Qi-Xu type, the glomerular segmental sclerosis, nodular changes,
and fibrinoid exudation were more serious than other groups. In the patients
with Yu-Xue syndrome differentiation, interstitial fibrosis and tubular atro-
phy (IFTA), interstitial inflammation, hyaline degeneration, angiosclerosis,
and fibrinoid exudation were more serious than other types significantly.
Multivariate COX analysis showed that syndrome differentiation were inde-
pendent risk factors for renal prognosis.
Conclusion: Among the syndrome differentiation of DKD, Qi-Yin-Liang-Xu
type and Yu-Xue type were more frequently than other tyes. The result
showed that syndrome differentiation was correlated significantly with path-
ological stage of DKD, Yin-Yang-Liang-Xu type and Tan-Yu type were inde-
pendent risk factors for renal prognosis in DKD.http://dx.doi.org/10.1016/j.hkjn.2015.08.0240096
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Objective: Diabetic nephropathy (DN) is one of the most severe microvascular
complications of diabetes. Recently, Berberine (BBR) has the beneficial effects
to diabetes. The aim of this study is to observe the renoprotective effect and
mechanisms of berberine in a type 2 diabetes nephropathy on rat.
Methods: Twenty seven male Wistar rats (8-wk old, 200e250 g) randomly
divided into 9 rats in normal control and 18 rats in diabetic groups. Diabetic
rats were fedwith a high-fat diet (consisting of 50% carbohydrate, 12% protein,
and 38% fat) for 5 wk, followed by intraperitoneal injection with a single low-
dose of streptozotocin (STZ, 25 mg/kg) after 12-h fasting. The normal control
rats were fed with a standard chow diet. Diabetic rats were randomly divided
into two subgroups: vehicle treated and BBR treated (nZ 9 each). Rats were
housed individually inmetabolic cages for 24-h urinary collection at 4-wk inter-
vals. Ratswere sacrificed 20weeks later.Wedetected the kidneyweight index,
24 h urine protein, morphology study, inflammation and fibrosis markers, such
as IkBa, TGFb1, TbRI and Smad7 by realtime-PCR and Western Blot.
Results: (1) Comparedwith normal rats, the diabetic rats showed higher kidney
weight index and 24h urine protein, berberine treatment decreased kidney
weight index and 24 h urine protein. (2) BBR treatment inhibited histological
injury including deposition of extracellular matrix, thickening of glomerular
basement membrane, and tubular atrophy of DN rats. (3) DN rats showed
decreased Smad7 mRNA and protein expression (P < 0.01), increased
TGFb1mRNA (P < 0.05) and TbRI protein expression (P < 0.05); however, BBR
treatment down-regulated TGFb1, TbRI level (P < 0.05), up-regulated Smad7,
IkBa level (P < 0.05).
Conclusion: Berberine has renoprotective effect on a type 2 diabetic rat
model. The mechanism might suppress inflammation and fibrosis via upregu-
lating expression of Smad7.http://dx.doi.org/10.1016/j.hkjn.2015.08.025
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Objectives: Tangshen Formula (TSF) is a Chinese herbal medicine used for
DN treatment. In the current study, we aimed to identify the core regulatory
region of QDPR gene promoter. We also studied whether the Tangshen For-
mula could up-regulate QDPR promoter activity in vitro study and to investi-
gate the Tangshen Formula’s mechanism at molecular level.
Results: Identification of core regulatory region in QDPR gene promoter: as
compared with 2092 w 1 fragment, the relative fluorescence intensity of
the deleted fragment 529 w 116 reduced to 1% (P < 0.01), the fragment
which contained 529w 1 kept 64% (P< 0.05). The relative fluorescence in-
tensity of those deleted fragments 529w 429, 428w 250 and 141w
116 were increased (P < 0.01), and the deleted fragment 249w 142 was
decreased (P< 0.05).QDPR gene promoter couldbe recognized as TangshenFor-
mula’s drug targets: LDH experimental data showed that: the suitable Tangshen
Formula’s concentration in cell experiment were 800 g/ml or less. Results
showed that: Tangshen Formula can improve QDPR gene promoter activity.
Tangshen Formula can improve D5’/pGL3, D3/pGL3, D4/pGL3 three recombi-
nant plasmids activity. But comparing with no drug treated group, drug treated
group is no effect on D1-4/pGL3, D1/pGL3, D2/pGL3’s activity (P> 0.01).
Conclusion: Rat QDPR core regulatory region might locate between 529 and
116 where existing putative negative and positive regulatory elements, espe-
cially, existing several Sp1 binding sites. There may be a potential Sp1 binding
sites at 141w 116 which could inhibit the transcriptional activity of the
promoter.
S8 Diabetic NephropathyQDPR promoter might be a potential target of TSF in treating DN. TSF’s drug
target may located between 529 and 250 promoter fragment.http://dx.doi.org/10.1016/j.hkjn.2015.08.026
0098
Meta-analysis of the Association of Prol2Ala Polymorphism of
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Objective: To evaluate the association of Pro12Ala polymorphism of Perox-
isome Proliferator Activated Receptor-gamma2 (PPARg2) gene with (diabetic
kidney disease, DKD) in Chinese Han population.
Methods: The present investigation was carried out using the keywords “dia-
betic kidney disease”, “DKD”, “diabetic nephropathy”, “DN”, “peroxisome
proliferator-activated receptor-gamma 2”, “PPARg2”, “polymorphism” and
“Prol2Ala”. PubMed. Chinese Biomedicine Database (CBM). China National
Knowledge Infrastructure (CNKI). Wanfang and VIP database were searched
for all relevant articles investigating the association between PPARg2
Pro12Ala polymorphism and DKD that were available. The odds ratios (OS)
for Alal2 used as the metric of choice were calculated in the dominant
and additive model separately. The Meta-analysis was conducted by softe-
ware Stata12.0.
Results: We identified 8 studies, involving 1439 DKD cases and 913 controls
fell into the inclusion criteria. The analysis indicated no significant inter-
study heterogeneity and publication bias. There was no heterogeneity
(PBegg, PEgger > 0.05) among the 8 qualified articles. The pooled OR (95%
CI) value of the frequencies of the PPARg2 genotype (PA+AA)/PP calculated
by fixed-effects model was 0.55 (0.34e0.71) (P < 0.05). A/P calculated by
fixed-effects model was 0.57 (0.45e0.73) (P < 0.05).
Conclusion: In this meta-analysis, the Prol2Ala gene variant (rsl801282) is
found to be associated with the susceptibility for DKD in Chinese Han
population.http://dx.doi.org/10.1016/j.hkjn.2015.08.027
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Objective: To evaluate the effectiveness and safety of Pro12Ala polymor-
phism of traditional Chinese medicine on diabetic kidney disease with
dyslipidemias.
Methods: All randomized or semi-randomized controlled trials (RCTs or semi-
RCTs) of traditional Chinese medicine in treating diabetic kidney disease
with dyslipidemias were collected from PubMed, Cochrane library, Chinese
Biomedicine Database (CBM), China National Knowledge Infrastructure
(CNKI). Wanfang and VIP database. After two researchers for screening
and data extraction independently, the quality of the included literature
research was evaluated according to the Cochrane risk of bias, then Revman
5.3 was used to undertake meta-analysis.
Results: We identified 8 studies, involving 449 patients. Experimental group
237 patients vs control group 212 patients. Meta analysis indicated that
traditional Chinese medicine treatment gave better results in lowering
serum total cholesterol (TC) [MD Z 1.21, 95%CI (1.75, 0.66)], total tri-
glyceride(TG) [MD Z 0.89, 95% CI (1.26, 0.52)]. But there is nostatistically significant for lowering high density lipoprotein cholesterol
(HDL-C) [MD Z 0.34, 95% CI (0.09, 0.77)] compared with control ther-
apy alone.
Conclusion: Traditional Chinese medicine significantly reduced TC, TG, and
improved total efficiency of the symptoms and signs in diabetic kidney dis-
ease with dyslipidemias.http://dx.doi.org/10.1016/j.hkjn.2015.08.028
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Background: The role of transcription factors SRF, which regulate CArG
element contained genes, in diabetic nephropathy is unknown.
Methods: Here we performed expression of SRF in human diabetic nephrop-
athy tissues and the cultured proximal tubular cells (HK-2) under high-
glucose or induced by TGF-bcompared with control conditions.
Results: We identified overexpression of SRF was observed in glucose-
induced HK-2 cells. Next, we performed SRF expression from formalin-fixed,
paraffin-embedded tissues from renal biopsies diagnosis as diabetic ne-
phropathy. We noted the greatest change in SRF expression, which was
significantly higher in late presenters compared with early presenters.
Furthermore, in individual biopsies, high expression of SRF correlated with
tubulointerstitial fibrosis and low estimated GFR. In vitro, treatment of
HK-2 with TGF-b increased SRF expression. Lower expression of SRF sup-
pressed expression of the CArG element snail1, thereby opposing TGF-b-
mediated downregulation of E-cadherin.
Conclusion: High expression of SRF associates with increased fibrosis and
decreased estimated GFR in diabetic nephropathy in vivo, perhaps by
enhancing TGF-b-mediated downregulation of snail in HK-2.http://dx.doi.org/10.1016/j.hkjn.2015.08.029
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Objectives: Angiotensin II (AngII) is an important effecter of the renal RAS
cascade and plays multiple roles in kidney disease. It has been reported
that AngII can cause podocyte injury by increasing intracellular calcium
influx. In this study, we test whether AngII can induce autophagy of podocyte
and the potential protective role of ginsenoside Rg1 in this process.
Methods: MPC5 cells (mouse podocyte cell line) were cultured with AngII and
the autophagy level was assessed by intracellular autophagosome number,
conversion of LC3-I to LC3-II and expression of Beclin-1. The intracellular
reactive oxygen species (ROS) level was determined by 2,7-dichlorofluores-
cin diacetate (DCFH-DA) assay. To investigate the protective role of ginseno-
side Rg1, MPC5 cells were pre-treated with ginsenoside Rg1 followed by AngII
stimulation. Western blot was employed to determine the phosphorylation
status of AMPK and P70S6K.
Results: Increased autophagy was observed in MPC5 cells stimulated by Ang
II as indicated by increased number of autophagosome, LC3-I to LC3-II
